Correspondence 0001493152-22-034107 from Lucid Diagnostics Inc. (LUCD)
Lucid Diagnostics Inc.
Date: Dec. 1, 2022 · CIK: 0001799011 · Accession: 0001493152-22-034107
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-268560
Letter
Lucid Diagnostics Inc.
One Grand Central Place, Suite 4600
New York, New York 10165
212-949-4319
December 1, 2022
VIA EDGAR
Division of Corporation Finance
Office of Industrial Applications and Services
Securities and Exchange Commission
F Street, N.E.
Washington, D.C. 20549
Attention: Sean Healy
Re:
Lucid Diagnostics Inc.
Registration Statement on Form S-3
File No. 333-268560
Ladies and Gentlemen:
Lucid Diagnostics Inc. (the “Company”) hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, acceleration of effectiveness of the above-referenced Registration Statement so that such Registration Statement will become effective as of 9:30 a.m., Tuesday, December 6, 2022, or as soon thereafter as practicable.
Very
truly yours,
LUCID
DIAGNOSTICS INC.
Show Raw Text
CORRESP
1
filename1.htm
Lucid
Diagnostics Inc.
One
Grand Central Place, Suite 4600
New
York, New York 10165
212-949-4319
December
1, 2022
VIA
EDGAR
Division
of Corporation Finance
Office
of Industrial Applications and Services
Securities
and Exchange Commission
100
F Street, N.E.
Washington,
D.C. 20549
Attention:
Sean Healy
Re:
Lucid
Diagnostics Inc.
Registration
Statement on Form S-3
File
No. 333-268560
Ladies
and Gentlemen:
Lucid
Diagnostics Inc. (the “Company”) hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933,
as amended, acceleration of effectiveness of the above-referenced Registration Statement so that such Registration Statement will become
effective as of 9:30 a.m., Tuesday, December 6, 2022, or as soon thereafter as practicable.
Very
truly yours,
LUCID
DIAGNOSTICS INC.
By:
/s/
Lishan Aklog, M.D.
Name:
Lishan
Aklog, M.D.
Title:
Chairman
and Chief Executive Officer